The underlying mechanisms that allow proinflammatory cytokines to exert a direct adverse effect on growth plate chondrogenesis are unclear. These effects may be mediated by ceramide, a sphingosine-based lipid second messenger, which is elevated in a number of chronic inflammatory diseases. To test this hypothesis, we determined the effects of C2-ceramide a cell permeable ceramide analogue, on the growth of the ATDC5 chondrogenic cell line and on cultured fetal mice metatarsals.
Introduction
Chronic inflammatory diseases such as Juvenile Idiopathic Arthritis (JIA) and Inflammatory Bowel Disease (IBD) often lead to childhood growth retardation through a number of proposed mechanisms that includes nutritional deficiency, chronic inflammation, increased catabolism, defects in the GH/IGF-1 axis and use of glucocorticoids (MacRae et al. 2006a; Wong et al. 2006) . Proinflammatory cytokines such as TNFα and IL-1β, are often raised in these diseases, and measures that block TNFα action such as anti-TNF therapy lead to an improvement in growth, an effect which has been reported to be independent of the concurrent reduction in the need for therapy with glucocorticoids (Tynjala et al. 2006 ). TNFα and IL-1β, may directly inhibit growth plate chondrocyte dynamics as well as longitudinal growth in vitro Martensson et al. 2004; MacRae et al. 2006b ) but the underlying mechanisms that lead to these effects are unclear.
The insulin-like growth factor-I (IGF-I) signalling pathway is the major autocrine/paracrine regulator of bone growth (Loveridge et al. 1990 ). Binding of IGF-I to its receptor utilises a family of soluble receptors, known as insulin receptor substrates (IRSs), to initiate a series of autophosphorylation events. This results in the activation of two distinct signalling pathways, phosphatidylinositol 3-kinase (PI-3K) and p44/p42 mitogen-activated protein kinase (MAPK), leading to pro-proliferative and anti-apoptotic effects.
In many cell types, signal transduction of IL-1β and TNFα involves the activation of neutral (N) and acidic (A) sphingomyelinase (Smase) pathways, which catalyse the 5 degradation of the membrane phospholipid sphingomyelin into phosphocholine and ceramide (Mathias et al. 1993; Weigmann et al. 1994 ; Rybakina et al. 2001 ).
Ceramide is also elevated through a de novo synthesis pathway following activation of IL-1β and TNFα receptors (Memon et al. 1998; Xu et al. 1998 reported. In this study, the ATDC5 chondrogenic cell line was used to characterise and compare the effects of ceramide on cell proliferation, differentiation and apoptosis. Subsequently, the effect of ceramide on IGF-1 signalling was examined using ATDC5 cells and the fetal murine metatarsal model.
Materials & Methods

Chondrocyte cell culture
The ATDC5 chondrocyte cell line was sourced from the RIKEN cell bank (Ibaraki, Japan) and maintained as described by Atsumi et al. (1990) The amount of radioactivity incorporated into trichloroacetic acid-insoluble precipitates was measured ).
Chondrocyte number, proliferation and apoptosis
Protein content was determined as a measure of cell number. Cells were cultured in 12 well plates, and exposed to C2-ceramide on Day 6 and Day 8. On Day 10, the cells were washed twice with phosphate buffered saline, lysed with 0.9% NaCl and 0.2% Triton X-100 and centrifuged at 12000g for 15min at 4°C. The protein content of the supernatant was measured using the Bio-Rad protein assay reagent (Bio-Rad Laboratories) based on the Bradford dye binding procedure, and gamma globulin as standard (Farquharson et al. 1995) . Proliferation was determined as described above.
Apoptosis of the cells was measured using the APO Percentage Apoptosis assay, (Biocolor Ltd, Belfast, N Ireland), which quantifies dye uptake by apoptotic cells only after the translocation of phosphatidylserine to the outer surface of the cell membrane (Fadok et al. 1992 ). Apoptosis was assessed following the manufacturer's protocol in cells cultured in 48 well plates over a 24-hour period starting on Day 6.
Analysis of chondrogenic gene expression
On days . The cycling profile was 1 min at 92°C (first cycle, 2 min), 1 min at 55°C, and 1 min at 70°C. The number of cycles performed was carefully titrated to ensure that the reactions were in the exponential phase. Reaction products were analysed on 1.5% agarose gels in the presence of ethidium bromide (250µg/l), and a digital image of each gel was captured using a gel documentation system (Bio-Rad Laboratories, Inc., Hemel Hempstead, Herts, UK).
IGF-1 studies in ATDC5 cells
The cells were treated with C2-ceramide (25µM) for 24h in the presence of IGF-1.
Proliferation was determined as described above. In further studies, the cells were Proliferation was determined as described above. The minimum concentration at which ceramide could inhibit IGF-1-induced proliferation in ATDC5 cells was examined using C2-ceramide concentrations between 10µM and 40µM at 5µM intervals using serum free medium. The membranes were washed and developed as described above.
Western blotting analysis
Organ culture
The middle three metatarsals were aseptically dissected from 19-day-old embryonic Swiss mice. Bones were cultured at 37°C in a humidified atmosphere of 95% air / 5% period, in the presence of IGF-1 (100ng/ml). The minimum concentration at which ceramide could affect metatarsal growth was examined using C2-ceramide concentrations between 0µM and 40µM at 10µM intervals using serum free medium in the fetal metatarsal culture model. In all experiments, the medium was changed every second/third day.
Morphometric analysis
Digital images of the metatarsals were captured every second day of culture and viewed on a Nikon Eclipse TE3000 microscope (Nikon, Kingston upon Thames Surrey, UK), using a digital camera (DS Camera Head DS-5M; Nikon). The total length of the bone through the centre of the mineralising zone was determined using image analysis software (DS Camera Control Unit DS-L1; Nikon). All results are expressed as a percentage change from harvesting length, which was regarded as baseline.
Statistical analysis
All experiments were performed at least twice. General Linear Model analysis was used to assess the data. All data are expressed as the mean +/-S.E.M. of six observations within each experiment. Statistical analysis was performed using Minitab 14. P<0.05 was considered to be significant.
Results
Ceramide generation following pro-inflammatory cytokine exposure.
TNFα (10ng/ml) significantly reduced proliferation compared to control cells ( Fig. 1; 93%; P<0.001). When added in the presence of TNFα, D609 (10µg/ml) significantly increased proliferation compared to cytokine treatment alone ( Fig. 1; 927%; P<0.001). D609 also significantly increased proliferation in control cells ( Fig. 1; 84%; P<0.001).
Characterisation of the effect of C2-ceramide on ATDC5 cells.
In the ATDC5 cells, 40µM C2-ceramide significantly reduced cell proliferation over a 24h period (Fig. 2a) , and this was confirmed when corrected for protein content (Fig.   2b) . Following a 5 day exposure period, both 40 and 25µM C2-ceramide significantly reduced cell number (protein content) (Fig. 2c) . Apoptosis was also increased at both concentrations following exposure for 24h (Fig. 2d) . There was no significant alteration in C2-ceramide-induced mRNA expression of markers of chondrogenesis or differentiation (sox 9, collagen II aggrecan and collagen X) at all concentrations studied (Fig. 3) .
IGF-1 studies
The lowest concentration of C2-ceramide that inhibited ATDC5 cell proliferation following 18h serum deprivation was 25µM in the presence of IGF-1 (Fig. 4a ). Cells exposed to C2-ceramide (25µM) in the presence or absence of IGF-1 (100ng/ml) for 24h indicated that IGF-1 alone significantly increased proliferation (Fig 4b; P<0.001 ).
In the presence of IGF-1, C2-ceramide induced a 68% reduction in proliferation ( Fig.   4b ; P<0.001). However, in the absence of IGF-1, ceramide induced a comparable 61% decrease ( Fig. 4b; P<0 .001).
In the more physiological fetal metatarsal model, the lowest concentration of C2-ceramide that significantly reduced fetal metatarsal growth was 40µM in the presence of IGF-1 ( Fig. 5a ; 62%; P<0.05). C2-ceramide (40µM) induced the same 31% reduction in metatarsal growth both in the presence and absence of IGF-1 (9d, 100ng/ml) ( Fig. 5b ; both P<0.001).
The effect of C2-ceramide on endogenous IGF-1 induced ATDC5 cell proliferation was examined, using AG1024, an IGF-1 and insulin receptor blocker (10µM) (Fig.   4c ). In the absence of exogenous IGF-1, AG1024, an IGF-1 and insulin receptor In conclusion, we have reported for the first time in growth plate chondrocytes, a link between pro-inflammatory cytokines and ceramide generation, and an antiproliferative and pro-apoptotic effect of ceramide. Interestingly, these effects appear to be IGF-1 independent. Inflammatory cytokine induced generation of ceramide, and its subsequent actions on the growth plate, may be associated with the abnormal growth observed in children suffering from chronic inflammatory diseases.
